 | • レポートコード：GIR-107A12518 • 出版社/出版日：GlobalInfoResearch / 2021年7月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、NSAIDs（非ステロイド系抗炎症）治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NSAIDs（非ステロイド系抗炎症）治療薬の種類別市場規模（イブプロフェン、ナプロキセン）、用途別市場規模（病院、クリニック、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・NSAIDs（非ステロイド系抗炎症）治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Allergan、Purdue ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：イブプロフェン、ナプロキセン ・用途別分析2016年-2026年：病院、クリニック、ドラッグストア ・NSAIDs（非ステロイド系抗炎症）治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・NSAIDs（非ステロイド系抗炎症）治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・NSAIDs（非ステロイド系抗炎症）治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・NSAIDs（非ステロイド系抗炎症）治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・NSAIDs（非ステロイド系抗炎症）治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The NSAIDs Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global NSAIDs Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global NSAIDs Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
NSAIDs Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ibuprofen
Naproxen
Market segment by Application, can be divided into
Hospitals
Clinics
Drugstores
Market segment by players, this report covers
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe NSAIDs Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of NSAIDs Drug, with revenue, gross margin and global market share of NSAIDs Drug from 2019 to 2021.
Chapter 3, the NSAIDs Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and NSAIDs Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe NSAIDs Drug research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of NSAIDs Drug
1.2 Classification of NSAIDs Drug by Type
1.2.1 Overview: Global NSAIDs Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NSAIDs Drug Revenue Market Share by Type in 2020
1.2.3 Ibuprofen
1.2.4 Naproxen
1.3 Global NSAIDs Drug Market by Application
1.3.1 Overview: Global NSAIDs Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Global NSAIDs Drug Market Size & Forecast
1.5 Global NSAIDs Drug Market Size and Forecast by Region
1.5.1 Global NSAIDs Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NSAIDs Drug Market Size by Region, (2016-2021)
1.5.3 North America NSAIDs Drug Market Size and Prospect (2016-2026)
1.5.4 Europe NSAIDs Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NSAIDs Drug Market Size and Prospect (2016-2026)
1.5.6 South America NSAIDs Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NSAIDs Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NSAIDs Drug Market Drivers
1.6.2 NSAIDs Drug Market Restraints
1.6.3 NSAIDs Drug Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer NSAIDs Drug Product and Solutions
2.1.4 Pfizer NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK NSAIDs Drug Product and Solutions
2.2.4 GSK NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GSK Recent Developments and Future Plans
2.3 Grunenthal
2.3.1 Grunenthal Details
2.3.2 Grunenthal Major Business
2.3.3 Grunenthal NSAIDs Drug Product and Solutions
2.3.4 Grunenthal NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Grunenthal Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer NSAIDs Drug Product and Solutions
2.4.4 Bayer NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi NSAIDs Drug Product and Solutions
2.5.4 Sanofi NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly NSAIDs Drug Product and Solutions
2.6.4 Eli Lilly NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca NSAIDs Drug Product and Solutions
2.7.4 AstraZeneca NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo NSAIDs Drug Product and Solutions
2.8.4 Endo NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Endo Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck NSAIDs Drug Product and Solutions
2.9.4 Merck NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Merck Recent Developments and Future Plans
2.10 Depomed
2.10.1 Depomed Details
2.10.2 Depomed Major Business
2.10.3 Depomed NSAIDs Drug Product and Solutions
2.10.4 Depomed NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Depomed Recent Developments and Future Plans
2.11 Yunnan Baiyao
2.11.1 Yunnan Baiyao Details
2.11.2 Yunnan Baiyao Major Business
2.11.3 Yunnan Baiyao NSAIDs Drug Product and Solutions
2.11.4 Yunnan Baiyao NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Yunnan Baiyao Recent Developments and Future Plans
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva NSAIDs Drug Product and Solutions
2.12.4 Teva NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Teva Recent Developments and Future Plans
2.13 J&J
2.13.1 J&J Details
2.13.2 J&J Major Business
2.13.3 J&J NSAIDs Drug Product and Solutions
2.13.4 J&J NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 J&J Recent Developments and Future Plans
2.14 Allergan
2.14.1 Allergan Details
2.14.2 Allergan Major Business
2.14.3 Allergan NSAIDs Drug Product and Solutions
2.14.4 Allergan NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Allergan Recent Developments and Future Plans
2.15 Purdue
2.15.1 Purdue Details
2.15.2 Purdue Major Business
2.15.3 Purdue NSAIDs Drug Product and Solutions
2.15.4 Purdue NSAIDs Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Purdue Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global NSAIDs Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 NSAIDs Drug Players Market Share
3.2.2 Top 10 NSAIDs Drug Players Market Share
3.2.3 Market Competition Trend
3.3 NSAIDs Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global NSAIDs Drug Revenue and Market Share by Type (2016-2021)
4.2 Global NSAIDs Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global NSAIDs Drug Revenue Market Share by Application (2016-2021)
5.2 NSAIDs Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America NSAIDs Drug Revenue by Type (2016-2026)
6.2 North America NSAIDs Drug Revenue by Application (2016-2026)
6.3 North America NSAIDs Drug Market Size by Country
6.3.1 North America NSAIDs Drug Revenue by Country (2016-2026)
6.3.2 United States NSAIDs Drug Market Size and Forecast (2016-2026)
6.3.3 Canada NSAIDs Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico NSAIDs Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe NSAIDs Drug Revenue by Type (2016-2026)
7.2 Europe NSAIDs Drug Revenue by Application (2016-2026)
7.3 Europe NSAIDs Drug Market Size by Country
7.3.1 Europe NSAIDs Drug Revenue by Country (2016-2026)
7.3.2 Germany NSAIDs Drug Market Size and Forecast (2016-2026)
7.3.3 France NSAIDs Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NSAIDs Drug Market Size and Forecast (2016-2026)
7.3.5 Russia NSAIDs Drug Market Size and Forecast (2016-2026)
7.3.6 Italy NSAIDs Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NSAIDs Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific NSAIDs Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific NSAIDs Drug Market Size by Region
8.3.1 Asia-Pacific NSAIDs Drug Revenue by Region (2016-2026)
8.3.2 China NSAIDs Drug Market Size and Forecast (2016-2026)
8.3.3 Japan NSAIDs Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea NSAIDs Drug Market Size and Forecast (2016-2026)
8.3.5 India NSAIDs Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NSAIDs Drug Market Size and Forecast (2016-2026)
8.3.7 Australia NSAIDs Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America NSAIDs Drug Revenue by Type (2016-2026)
9.2 South America NSAIDs Drug Revenue by Application (2016-2026)
9.3 South America NSAIDs Drug Market Size by Country
9.3.1 South America NSAIDs Drug Revenue by Country (2016-2026)
9.3.2 Brazil NSAIDs Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina NSAIDs Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NSAIDs Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa NSAIDs Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa NSAIDs Drug Market Size by Country
10.3.1 Middle East & Africa NSAIDs Drug Revenue by Country (2016-2026)
10.3.2 Turkey NSAIDs Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NSAIDs Drug Market Size and Forecast (2016-2026)
10.3.4 UAE NSAIDs Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global NSAIDs Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global NSAIDs Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market NSAIDs Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global NSAIDs Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global NSAIDs Drug Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer NSAIDs Drug Product and Solutions
Table 9. Pfizer NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GSK Corporate Information, Head Office, and Major Competitors
Table 11. GSK Major Business
Table 12. GSK NSAIDs Drug Product and Solutions
Table 13. GSK NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Grunenthal Corporate Information, Head Office, and Major Competitors
Table 15. Grunenthal Major Business
Table 16. Grunenthal NSAIDs Drug Product and Solutions
Table 17. Grunenthal NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer NSAIDs Drug Product and Solutions
Table 21. Bayer NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi NSAIDs Drug Product and Solutions
Table 25. Sanofi NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly NSAIDs Drug Product and Solutions
Table 29. Eli Lilly NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca NSAIDs Drug Product and Solutions
Table 33. AstraZeneca NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Endo Corporate Information, Head Office, and Major Competitors
Table 35. Endo Major Business
Table 36. Endo NSAIDs Drug Product and Solutions
Table 37. Endo NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Merck Corporate Information, Head Office, and Major Competitors
Table 39. Merck Major Business
Table 40. Merck NSAIDs Drug Product and Solutions
Table 41. Merck NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Depomed Corporate Information, Head Office, and Major Competitors
Table 43. Depomed Major Business
Table 44. Depomed NSAIDs Drug Product and Solutions
Table 45. Depomed NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Yunnan Baiyao Corporate Information, Head Office, and Major Competitors
Table 47. Yunnan Baiyao Major Business
Table 48. Yunnan Baiyao NSAIDs Drug Product and Solutions
Table 49. Yunnan Baiyao NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Teva Corporate Information, Head Office, and Major Competitors
Table 51. Teva Major Business
Table 52. Teva NSAIDs Drug Product and Solutions
Table 53. Teva NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. J&J Corporate Information, Head Office, and Major Competitors
Table 55. J&J Major Business
Table 56. J&J NSAIDs Drug Product and Solutions
Table 57. J&J NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Allergan Corporate Information, Head Office, and Major Competitors
Table 59. Allergan Major Business
Table 60. Allergan NSAIDs Drug Product and Solutions
Table 61. Allergan NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Purdue Corporate Information, Head Office, and Major Competitors
Table 63. Purdue Major Business
Table 64. Purdue NSAIDs Drug Product and Solutions
Table 65. Purdue NSAIDs Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global NSAIDs Drug Revenue (USD Million) by Players (2019-2021)
Table 67. Global NSAIDs Drug Revenue Share by Players (2019-2021)
Table 68. Breakdown of NSAIDs Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. NSAIDs Drug Players Head Office, Products and Services Provided
Table 70. NSAIDs Drug Mergers & Acquisitions in the Past Five Years
Table 71. NSAIDs Drug New Entrants and Expansion Plans
Table 72. Global NSAIDs Drug Revenue (USD Million) by Type (2016-2021)
Table 73. Global NSAIDs Drug Revenue Share by Type (2016-2021)
Table 74. Global NSAIDs Drug Revenue Forecast by Type (2021-2026)
Table 75. Global NSAIDs Drug Revenue by Application (2016-2021)
Table 76. Global NSAIDs Drug Revenue Forecast by Application (2021-2026)
Table 77. North America NSAIDs Drug Revenue by Type (2016-2021) & (USD Million)
Table 78. North America NSAIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 79. North America NSAIDs Drug Revenue by Application (2016-2021) & (USD Million)
Table 80. North America NSAIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 81. North America NSAIDs Drug Revenue by Country (2016-2021) & (USD Million)
Table 82. North America NSAIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe NSAIDs Drug Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe NSAIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe NSAIDs Drug Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe NSAIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe NSAIDs Drug Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe NSAIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific NSAIDs Drug Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific NSAIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific NSAIDs Drug Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific NSAIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific NSAIDs Drug Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific NSAIDs Drug Revenue by Region (2021-2026) & (USD Million)
Table 95. South America NSAIDs Drug Revenue by Type (2016-2021) & (USD Million)
Table 96. South America NSAIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 97. South America NSAIDs Drug Revenue by Application (2016-2021) & (USD Million)
Table 98. South America NSAIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 99. South America NSAIDs Drug Revenue by Country (2016-2021) & (USD Million)
Table 100. South America NSAIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa NSAIDs Drug Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa NSAIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa NSAIDs Drug Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa NSAIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa NSAIDs Drug Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa NSAIDs Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. NSAIDs Drug Picture
Figure 2. Global NSAIDs Drug Revenue Market Share by Type in 2020
Figure 3. Ibuprofen
Figure 4. Naproxen
Figure 5. NSAIDs Drug Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Drugstores Picture
Figure 9. Global NSAIDs Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global NSAIDs Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global NSAIDs Drug Revenue Market Share by Region (2016-2026)
Figure 12. Global NSAIDs Drug Revenue Market Share by Region in 2020
Figure 13. North America NSAIDs Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe NSAIDs Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific NSAIDs Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America NSAIDs Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa NSAIDs Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. NSAIDs Drug Market Drivers
Figure 19. NSAIDs Drug Market Restraints
Figure 20. NSAIDs Drug Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. GSK Recent Developments and Future Plans
Figure 23. Grunenthal Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Eli Lilly Recent Developments and Future Plans
Figure 27. AstraZeneca Recent Developments and Future Plans
Figure 28. Endo Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Depomed Recent Developments and Future Plans
Figure 31. Yunnan Baiyao Recent Developments and Future Plans
Figure 32. Teva Recent Developments and Future Plans
Figure 33. J&J Recent Developments and Future Plans
Figure 34. Allergan Recent Developments and Future Plans
Figure 35. Purdue Recent Developments and Future Plans
Figure 36. Global NSAIDs Drug Revenue Share by Players in 2020
Figure 37. NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players NSAIDs Drug Revenue Market Share in 2020
Figure 39. Global Top 10 Players NSAIDs Drug Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global NSAIDs Drug Revenue Share by Type in 2020
Figure 42. Global NSAIDs Drug Market Share Forecast by Type (2021-2026)
Figure 43. Global NSAIDs Drug Revenue Share by Application in 2020
Figure 44. Global NSAIDs Drug Market Share Forecast by Application (2021-2026)
Figure 45. North America NSAIDs Drug Sales Market Share by Type (2016-2026)
Figure 46. North America NSAIDs Drug Sales Market Share by Application (2016-2026)
Figure 47. North America NSAIDs Drug Revenue Market Share by Country (2016-2026)
Figure 48. United States NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe NSAIDs Drug Sales Market Share by Type (2016-2026)
Figure 52. Europe NSAIDs Drug Sales Market Share by Application (2016-2026)
Figure 53. Europe NSAIDs Drug Revenue Market Share by Country (2016-2026)
Figure 54. Germany NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific NSAIDs Drug Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific NSAIDs Drug Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific NSAIDs Drug Revenue Market Share by Region (2016-2026)
Figure 62. China NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America NSAIDs Drug Sales Market Share by Type (2016-2026)
Figure 69. South America NSAIDs Drug Sales Market Share by Application (2016-2026)
Figure 70. South America NSAIDs Drug Revenue Market Share by Country (2016-2026)
Figure 71. Brazil NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa NSAIDs Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa NSAIDs Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa NSAIDs Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE NSAIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source